LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 55 filers reported holding LARIMAR THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,154,127 | +26.2% | 292,184 | 0.0% | 0.24% | +58.1% |
| Q2 2023 | $914,536 | -30.9% | 292,184 | 0.0% | 0.16% | -45.6% |
| Q1 2023 | $1,323,594 | +9.7% | 292,184 | 0.0% | 0.28% | -31.5% |
| Q4 2022 | $1,206,720 | +29.1% | 292,184 | 0.0% | 0.42% | +23.4% |
| Q3 2022 | $935,000 | +63.2% | 292,184 | 0.0% | 0.34% | +86.2% |
| Q2 2022 | $573,000 | -51.6% | 292,184 | 0.0% | 0.18% | -29.0% |
| Q1 2022 | $1,183,000 | -62.5% | 292,184 | 0.0% | 0.26% | -41.8% |
| Q4 2021 | $3,153,000 | -6.4% | 292,184 | 0.0% | 0.44% | +9.8% |
| Q3 2021 | $3,369,000 | +17.4% | 292,184 | 0.0% | 0.40% | +33.9% |
| Q2 2021 | $2,869,000 | -32.8% | 292,184 | 0.0% | 0.30% | -62.2% |
| Q1 2021 | $4,269,000 | -31.8% | 292,184 | 0.0% | 0.79% | -43.8% |
| Q4 2020 | $6,256,000 | +41.2% | 292,184 | 0.0% | 1.40% | +88.1% |
| Q3 2020 | $4,432,000 | +18.0% | 292,184 | 0.0% | 0.75% | -22.1% |
| Q2 2020 | $3,755,000 | – | 292,184 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 1,515,148 | $22,136,000 | 4.43% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,144,539 | $75,162,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 191,945 | $2,804,000 | 1.53% |
| Atlas Venture Advisors, Inc. | 292,184 | $4,269,000 | 0.79% |
| Sio Capital Management, LLC | 187,223 | $2,735,000 | 0.56% |
| Vivo Capital, LLC | 799,662 | $11,683,000 | 0.41% |
| Altium Capital Management LP | 93,261 | $1,363,000 | 0.38% |
| RA Capital Management | 1,515,151 | $22,136,000 | 0.33% |
| Logos Global Management LP | 230,000 | $3,360,000 | 0.33% |
| DAFNA Capital Management LLC | 81,432 | $1,190,000 | 0.28% |